|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 3623386 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19194817.3 |
| Date of filing the European patent application | 2016-01-08 | |
| (97) | Date of publication of the European application | 2020-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation | 2022-08-10 |
| (30) | Number | Date | Country code |
| PCT/EP2015/050255 | 2015-01-08 | WO |
| (72) |
SAHIN, Ugur , DE
GIESEKE, Friederike , DE
ALTINTAS, Isil , NL
SATIJN, David , NL
PARREN, Paul , NL
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
Genmab A/S , Kalvebod Brygge 43, 1560 Copenhagen V, DK |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Agonistiniai TNF receptorius surišantys agentai |
| AGONISTIC TNF RECEPTOR BINDING AGENTS |
| Payment date | Validity (years) | Amount | |
| 2025-12-29 | 11 | 289.00 EUR |
| 2027-01-08 |